Association between Erectile Dysfunction and Lower Urinary Tract Symptoms in Patients with Benign Prostatic Enlargement
Abstract
Background Lower urinary tract symptoms and erectile dysfunction are common clinical conditions in men over the age of forty years. Bothconditions have been said to co-exist. No etiological link has been consistently stated. The two clinical conditions have beenreported in patients with benign prostate enlargement. Patients with this condition may present with poor urinary stream, urinarystraining, and poor erection among others. We investigated the association between lower urinary tract symptoms and erectiledysfunction in patients with benign prostatic enlargement. Method This was a prospective hospital-based study. All patients with lower urinary tract symptoms (LUTS) due to benign prostaticenlargement (BPE) which was established following clinical, laboratory and sonographic evidence. Consenting patients wererequested to complete International Prostate Symptoms Score (IPSS) and International Index of Erectile Function (IIEF-5)questionnaires to determine the severity of LUTS and erectile functions respectively. The data was analyzed using SPSS version23. Results The age distribution showed a range of 44-80years with a mean of 65.8years +/ 8SD. Majority of the study group were Yoruba(68, 73.1%). Majority of the patients presented with severe LUTS (76, 81.7%). (79, 79.4%) of the study group presented witherectile dysfunction. Although 79.4% of the studied population reported erectile dysfunction (ED). There was no significantcorrelation between LUTS/BPH and ED (p value…
Read the paper
Related studies
- Luteolin rescues postmenopausal osteoporosis elicited by OVX through alleviating osteoblast pyroptosis via activating PI3K-AKT signaling
- Drugs Used in “Chemsex”/Sexualized Drug Behaviour—Overview of the Related Clinical Psychopharmacological Issues
- Luteolin Inhibits Dexamethasone‐Induced Osteoporosis by Autophagy Activation Through miR‐125b‐5p/SIRT3/AMPK/mTOR Axis, an In Vitro and In Vivo Study
- Cutting-edge insights into liver fibrosis: advanced therapeutic strategies and future perspectives using engineered mesenchymal stem cell-derived exosomes
- Can we predict and manage persistent storage and voiding LUTS following bladder outflow resistance reduction surgery in men? ICI‐RS 2023
- Chylomicron-mimicking supramolecular nano emulsion for oral luteolin delivery against hyperuricemia
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.